{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:32:18Z","timestamp":1780677138027,"version":"3.54.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Hyperuricemia is a serious health problem related to not only gout but also cardiovascular diseases (CVDs). Low-dose aspirin was reported to inhibit uric acid excretion, which leads to hyperuricemia. To decrease hyperuricemia-related CVD, this study aimed to identify the risk of hyperuricemia in people taking aspirin.<\/jats:p><jats:p><jats:bold>Method:<\/jats:bold> The original data of this cross-sectional study were obtained from the National Health and Nutrition Examination Survey between 2011 and 2018. Participants who filled in the \u201cPreventive Aspirin Use\u201d questionnaire with a positive answer were included in the analysis. Six machine learning algorithms were screened, and eXtreme Gradient Boosting (XGBoost) was employed to establish a model to predict the risk of hyperuricemia.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 805 participants were enrolled in the final analysis, of which 190 participants had hyperuricemia. The participants were divided into a training set and testing set at a ratio of 8:2. The area under the curve for the training set was 0.864 and for the testing set was 0.811. The SHapley Additive exPlanations (SHAP) method was used to evaluate the performances of the modeling. Based on the SHAP results, the feature ranking interpretation showed that the estimated glomerular filtration rate, body mass index, and waist circumference were the three most important features for hyperuricemia in individuals taking aspirin. In addition, triglyceride, hypertension, total cholesterol, high-density lipoprotein, low-density lipoprotein, age, race, and smoking were also correlated with the development of hyperuricemia.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> A predictive model established by XGBoost algorithms can potentially help clinicians make an early detection of hyperuricemia risk in people taking low-dose aspirin.<\/jats:p>","DOI":"10.3389\/fphar.2023.1276149","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T04:52:26Z","timestamp":1705639946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Prediction of hyperuricemia in people taking low-dose aspirin using a machine learning algorithm: a cross-sectional study of the National Health and Nutrition Examination Survey"],"prefix":"10.3389","volume":"14","author":[{"given":"Bin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccl.2021.04.009","article-title":"The impact of uric acid and hyperuricemia on cardiovascular and renal systems","volume":"39","author":"Agnoletti","year":"2021","journal-title":"Cardiol. Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/rheumatology\/kew293","article-title":"Drug-induced hyperuricaemia and gout","volume":"56","author":"Ben","year":"2017","journal-title":"RHEUMATOLOGY"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.3390\/ijerph19116713","article-title":"Association of hyperuricemia with 10-year atherosclerotic cardiovascular disease risk among Chinese adults and elders","volume":"19","author":"Chen","year":"2022","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022","volume":"45","author":"Committee","year":"2022","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/jama.2022.4983","article-title":"Aspirin use to prevent cardiovascular disease: US preventive services task force recommendation statement","volume":"327","author":"Davidson","year":"2022","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1056\/NEJMc2104626","article-title":"The clinician and dataset shift in artificial intelligence","volume":"385","author":"Finlayson","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12874-022-01824-1","article-title":"A hybrid machine learning framework to improve prediction of all-cause rehospitalization among elderly patients in Hong Kong","volume":"23","author":"Guan","year":"2023","journal-title":"BMC Med. Res. Methodol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1001\/jama.2022.3337","article-title":"Aspirin use to prevent cardiovascular disease and colorectal cancer: updated evidence report and systematic review for the US preventive services task force","volume":"327","author":"Guirguis-Blake","year":"2022","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/joim.12822","article-title":"eDoctor: machine learning and the future of medicine","volume":"284","author":"Handelman","year":"2018","journal-title":"J. Intern. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"11317","DOI":"10.3390\/ijms231911317","article-title":"Aspirin resistance in vascular disease: a review highlighting the critical need for improved point-of-care testing and personalized therapy","volume":"23","author":"Khan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e2248685","DOI":"10.1001\/jamanetworkopen.2022.48685","article-title":"Development of a machine learning model for sonographic assessment of gestational age","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw. Open."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.mayocp.2022.02.027","article-title":"Lowering and raising serum urate levels: off-label effects of commonly used medications","volume":"97","author":"Leung","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.2147\/IJGM.S320378","article-title":"Association between low-dose aspirin and uric acid in the elderly: an observational retrospective cross-sectional study","volume":"14","author":"Li","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e2322285","DOI":"10.1001\/jamanetworkopen.2023.22285","article-title":"Development and validation of a machine learning model to identify patients before surgery at high risk for postoperative adverse events","volume":"6","author":"Mahajan","year":"2023","journal-title":"JAMA Netw. Open."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e2345892","DOI":"10.1001\/jamanetworkopen.2023.45892","article-title":"Perceptions of data set experts on important characteristics of health data sets ready for machine learning: a qualitative study","volume":"6","author":"Ng","year":"2023","journal-title":"JAMA Netw. Open."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1016\/S2589-7500(22)00170-4","article-title":"Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials","volume":"4","author":"Oikonomou","year":"2022","journal-title":"Lancet Digit. Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e18172","DOI":"10.7759\/cureus.18172","article-title":"Hyperuricemia and its association with ischemic stroke","volume":"13","author":"Padda","year":"2021","journal-title":"Cureus J. Med. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1080\/0886022X.2020.1822185","article-title":"Hyperuricemia, the heart, and the kidneys - to treat or not to treat?","volume":"42","author":"Petreski","year":"2020","journal-title":"Ren. Fail."},{"key":"B21","first-page":"679","article-title":"Renal effects of low dose aspirin in elderly patients","volume":"8","author":"Segal","year":"2006","journal-title":"Isr. Med. Assoc. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000502438","article-title":"Elevated serum uric acid and self-reported heart failure in US adults: 2007-2016 national health and nutrition examination survey","volume":"9","author":"Stone","year":"2019","journal-title":"CardioRenal Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1080\/01616412.2022.2067707","article-title":"Can hyperuricemia predict the progression risk of cerebral small vessel disease?","volume":"44","author":"Wei","year":"2022","journal-title":"Neurol. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1161\/CIR.0000000000000597","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of cardiology\/American heart association task force on clinical practice guidelines","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ejvs.2003.12.025","article-title":"Aspirin resistance in cardiovascular disease: a review","volume":"27","author":"Wong","year":"2004","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29219\/fnr.v64.3641","article-title":"Associations between dietary iron intake from different sources and the risk of hyperuricemia among US adults: a cross-sectional study","volume":"64","author":"Yu","year":"2020","journal-title":"Food Nutr. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"791983","DOI":"10.3389\/fimmu.2021.791983","article-title":"Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2174\/1381612825666190408122557","article-title":"Hyperuricemia and cardiovascular disease","volume":"25","author":"Zhang","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"B29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/annrheumdis-2012-202589","article-title":"Low-dose aspirin use and recurrent gout attacks","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e939546","DOI":"10.12659\/MSM.939546","article-title":"Exploring the association between low-dose aspirin intake and hyperuricemia in individuals over 40: a cross-sectional study using NHANES data (2011-2018)","volume":"29","author":"Zhu","year":"2023","journal-title":"Med. Sci. Monit."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1276149\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T04:52:27Z","timestamp":1705639947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1276149\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":30,"alternative-id":["10.3389\/fphar.2023.1276149"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1276149","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]},"article-number":"1276149"}}